Master this deck with 55 terms through effective study methods.
Generated from text input
Blocks blood flow in deep veins, often in legs.
Primarily in the legs, but can affect the pelvis.
1-2 cases per 1,000 people annually.
DVTs account for two-thirds of VTE cases.
Incidence can reach up to 37%.
Approximately 100 cases per 100,000 person-years.
Incidence peaks between 60-70 years.
The sex ratio is approximately 1:1.
Results from venous thromboembolism due to risk factors.
Includes thrombophilia, hormonal factors, and obesity.
Older age and male gender are significant factors.
Immobilization and hospitalization significantly increase risk.
20% of DVT patients have cancer; screening is essential.
Pregnancy increases risk 5x; obesity 2-3x if BMI >30.
Hypercoagulability, blood stasis, and endothelial changes.
Increases clotting tendency due to genetic or acquired factors.
Promotes clot formation, especially during immobilization.
Disruption of vein lining initiates thrombosis.
Unilateral swelling, warmth, pain, and erythema.
Commonly in the lower leg, worsened by exertion.
Usually confined to calves; may cause whole-leg swelling.
Discoloration and distended superficial veins may occur.
Yes, up to 30% may show no symptoms.
A 65-year-old post-surgical patient with leg pain and swelling.
Sudden shortness of breath may suggest pulmonary embolism.
Cellulitis presents with unilateral erythema and fever.
Calf muscle tear shows swelling and pain after trauma.
Superficial thrombophlebitis causes localized pain and erythema.
Dependent edema presents as bilateral swelling.
Ruptured Baker’s cyst causes calf pain and bruising.
Perform a two-level DVT Wells score.
Includes active cancer, leg swelling, and prior DVT.
DVT is likely; order a proximal leg vein ultrasound.
Perform a D-dimer test to rule out DVT.
Conduct a D-dimer test and start interim anticoagulation.
DVT is unlikely; perform a D-dimer test.
Order a proximal leg vein ultrasound within 4 hours.
DVT is unlikely; stop anticoagulation if started.
Repeat ultrasound in 6-8 days.
Point-of-care or laboratory-based tests with age adjustments.
FBC, U&Es, LFTs, and coagulation screen.
Direct oral anticoagulants like apixaban or rivaroxaban.
LMWH for ≥5 days followed by dabigatran or warfarin.
Tailored based on cancer status and renal function.
At least 3 months for all patients.
Typically stopped at 3 months.
Consider continuing up to 6 months.
Test for thrombophilia and screen for cancer.
Pulmonary embolism occurs in 40-50% of cases.
Chronic venous hypertension causing pain and swelling.
No, they are not advised for prevention.
Use compression stockings and elevate the leg.
Includes gastrointestinal bleeding from anticoagulation.
Most recover, but complications can affect quality of life.
Timely treatment reduces PE risk and morbidity.